ADR 851

• Description :

  ADR 851 is a dopamine D2 receptor antagonist, and can be used in research on antiemetics[1].

• UNSPSC :

  12352005

• Target :

  Dopamine Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/adr-851.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(C1=C(OCC2)C2=C(N)C(Cl)=C1)NC[C@H]3NCCC3.Cl

• Molecular Formula :

  C14H19Cl2N3O2

• Molecular Weight :

  332.23

• References & Citations :

  [1]Monković I, et al. 7 Developments in the Antiemetic Area: Chemistry, Pharmacology and Therapy[J]. Progress in medicinal chemistry, 1990, 27: 297-323.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 1

• CAS Number :

  [123805-17-4]